SCHEMBL5784398

SCHEMBL5784398

NCc1cc(-c2cccc(CN3C(=O)c4cccc(NC(=O)C5=CC(Cl)=CCC5=S)c4C3=O)c2)ccc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.38
HDAC4 P56524 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
MAPT P10636 5/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPK1 P28482 1/20 0.37
ACHE P22303 1/20 0.36
GRM5 P41594 6/20 0.34
CA9 Q16790 1/20 0.32
F11 P03951 1/20 0.32
SUCNR1 Q9BXA5 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA4 P22748 1/20 0.32
CA7 P43166 1/20 0.32
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5779462 0.87 MAPT (0.41) HDAC1MAPTKDM4EMAPK1ACHE
SCHEMBL5781841 0.85 HDAC1 (0.43) HDAC1HDAC4HDAC7HDAC8HDAC6
SCHEMBL5779832 0.84 MAPT (0.43) HDAC1MAPTKDM4EMAPK1ACHE
SCHEMBL5781955 0.83 ACHE (0.41) HDAC1HDAC4HDAC7HDAC8HDAC6
SCHEMBL5780762 0.83 HDAC1 (0.43) HDAC1HDAC4HDAC7HDAC8HDAC6
SCHEMBL5781764 0.82 ACHE (0.41) HDAC1HDAC4HDAC7HDAC8HDAC6
SCHEMBL5781913 0.81 MAPT (0.39) HDAC1MAPTKDM4EMAPK1ACHE
SCHEMBL5785216 0.81 ACHE (0.40) HDAC1HDAC4HDAC7HDAC8HDAC6
SCHEMBL5784393 0.80 F10 (0.42) HDAC1HDAC4HDAC7HDAC8HDAC6
SCHEMBL5780092 0.80 ACHE (0.39) HDAC1MAPTKDM4EMAPK1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1408962-B1 SUBSTITUTED ISOINDOLES AND THE USE THEREOF BAYER HEALTHCARE AG (DE) 2006-03-15 EP disclosed